Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma

Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma

The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ε (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Klaus STREIN, Minh Diem VU, Jesus Fernando SAN MIGUEL IZQUIERDO, Bruno David Lourenco PAIVA
Format: Patent
Sprache:eng ; heb
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Klaus STREIN
Minh Diem VU
Jesus Fernando SAN MIGUEL IZQUIERDO
Bruno David Lourenco PAIVA
description The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ε (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL266424B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL266424B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL266424B23</originalsourceid><addsrcrecordid>eNqFyrEKwjAQgOEuDqI-g_cCLrX0ASqKgqN7uSbXcJC7C00y9O0VcXf64OffNmngnMjxzA5QC0_mV8CArLnA5AQ_1YPz56-owCJVLVpghxH8UgPMtoAzmVjJQ80ErFAWwsIaQGosnCKBrBRNcN9sZoyZDj93zfF2fV3uJ0o2Uk7oSKmMj2fb913bDe35__EG9YFCEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma</title><source>esp@cenet</source><creator>Klaus STREIN ; Minh Diem VU ; Jesus Fernando SAN MIGUEL IZQUIERDO ; Bruno David Lourenco PAIVA</creator><creatorcontrib>Klaus STREIN ; Minh Diem VU ; Jesus Fernando SAN MIGUEL IZQUIERDO ; Bruno David Lourenco PAIVA</creatorcontrib><description>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ε (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..</description><language>eng ; heb</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230901&amp;DB=EPODOC&amp;CC=IL&amp;NR=266424B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230901&amp;DB=EPODOC&amp;CC=IL&amp;NR=266424B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Klaus STREIN</creatorcontrib><creatorcontrib>Minh Diem VU</creatorcontrib><creatorcontrib>Jesus Fernando SAN MIGUEL IZQUIERDO</creatorcontrib><creatorcontrib>Bruno David Lourenco PAIVA</creatorcontrib><title>Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma</title><description>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ε (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEKwjAQgOEuDqI-g_cCLrX0ASqKgqN7uSbXcJC7C00y9O0VcXf64OffNmngnMjxzA5QC0_mV8CArLnA5AQ_1YPz56-owCJVLVpghxH8UgPMtoAzmVjJQ80ErFAWwsIaQGosnCKBrBRNcN9sZoyZDj93zfF2fV3uJ0o2Uk7oSKmMj2fb913bDe35__EG9YFCEQ</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Klaus STREIN</creator><creator>Minh Diem VU</creator><creator>Jesus Fernando SAN MIGUEL IZQUIERDO</creator><creator>Bruno David Lourenco PAIVA</creator><scope>EVB</scope></search><sort><creationdate>20230901</creationdate><title>Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma</title><author>Klaus STREIN ; Minh Diem VU ; Jesus Fernando SAN MIGUEL IZQUIERDO ; Bruno David Lourenco PAIVA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL266424B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Klaus STREIN</creatorcontrib><creatorcontrib>Minh Diem VU</creatorcontrib><creatorcontrib>Jesus Fernando SAN MIGUEL IZQUIERDO</creatorcontrib><creatorcontrib>Bruno David Lourenco PAIVA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Klaus STREIN</au><au>Minh Diem VU</au><au>Jesus Fernando SAN MIGUEL IZQUIERDO</au><au>Bruno David Lourenco PAIVA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma</title><date>2023-09-01</date><risdate>2023</risdate><abstract>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ε (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL266424B2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Klaus%20STREIN&rft.date=2023-09-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL266424B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true